- All
- Post
- Page
Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy
According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…
Patient Experience and Patient Outcomes: A Comprehensive Guide
Specialty Pharmacy Patient Experience and Patient Outcomes: A Comprehensive Guide Shields Health Solutions 11 min read Table of contents Contact Us Overview: Patient experience and patient outcomes, while two unique…
Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions
Whether through social media, traditional news outlets, or word of mouth, discussions about GLP-1 therapy are everywhere. These medications, originally approved by the FDA for the treatment of Type 2…
Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happening
Every year, more than 8,000 professionals and over 1,400 companies attend the leading specialty pharmacy conference in the nation, Asembia Summit 2024 marked its 20th anniversary — and we couldn’t be…
Shields Outcomes 2024 Report
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy
This poster evaluates the clinical and quality outcomes of a bleeding disorder program at a health system HSSP.
Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation
This poster aims to establish goals for a dashboard displaying medication adherence by disease state and PDC thresholds through a comprehensive literature review, validating the existing targets.
Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Cystic Fibrosis Patients
This poster explores the impact of a Health System Specialty Pharmacy care model paired with a pharmacist-led CDTM program on CF patient outcomes.
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
This article was published in MedCity News on November 18, 2024. The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for…